Spin-off SironRX raises $3.4M to advance treatment of post-surgical wounds
This article was originally published in Scrip
Executive Summary
The Cleveland, Ohio-based company, SironRX Therapeutics, yet another spin off from Cleveland Clinic, is developing novel regenerative therapies to accelerate dermal and bone healing, and has just closed a $3.4 million Series A venture round, led by the Ohio-based North Coast Angel Fund.